🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

144,67 USD

Máx. histórico

156,45

70 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-7,53%

Rango 52 semanas

82,01 – 156,92

Variación hoy

-2,49%

Cierre anterior

148,36

Rango de hoy

143,47 – 147,62

Volumen hoy

8.862.415

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,42%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
146,13 (puede no estar actualizado)
Dividend yield
2,29% (puede no estar actualizado)
Precio objetivo analistas
160,29 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 9 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,35%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/02/2024 126,71 127,56 126,11 126,41 +0,02% 1,14% 10.175.600
01/02/2024 123,65 126,43 122,77 126,38 +4,64% 2,96% 11.650.700
31/01/2024 122,53 122,85 120,50 120,78 -0,72% 1,92% 10.779.000
30/01/2024 121,28 121,76 120,18 121,66 +0,31% 1,30% 7.469.500
29/01/2024 121,35 121,46 120,49 121,28 +0,38% 0,80% 9.138.200
26/01/2024 120,51 121,02 120,08 120,82 +0,57% 0,78% 8.300.300
25/01/2024 118,66 120,18 118,66 120,13 +1,05% 1,28% 6.689.800
24/01/2024 119,70 119,95 118,44 118,88 -0,80% 1,26% 5.859.900
23/01/2024 118,14 119,99 117,27 119,84 +0,34% 2,30% 6.501.400
22/01/2024 119,04 119,97 118,86 119,43 +0,45% 0,93% 8.786.200
19/01/2024 118,21 119,02 117,72 118,89 +0,30% 1,10% 7.605.600
18/01/2024 117,65 118,62 116,62 118,54 +0,35% 1,70% 10.524.700
17/01/2024 119,18 119,40 117,61 118,13 -0,30% 1,50% 5.591.400
16/01/2024 118,49 119,34 117,94 118,49 -0,12% 1,18% 6.832.300
12/01/2024 118,07 118,67 117,65 118,63 +0,17% 0,86% 6.823.300
11/01/2024 118,80 118,90 117,08 118,43 -0,36% 1,53% 5.754.400
10/01/2024 118,19 119,17 117,74 118,86 +0,36% 1,21% 7.129.100
09/01/2024 117,51 119,94 117,21 118,43 +0,89% 2,32% 8.822.300
08/01/2024 117,59 117,89 116,18 117,38 +0,14% 1,45% 8.193.100
05/01/2024 117,10 117,45 116,64 117,22 +0,18% 0,69% 6.861.500
04/01/2024 115,92 117,65 115,86 117,01 +1,95% 1,54% 11.492.200
03/01/2024 114,27 115,90 114,16 114,77 +1,35% 1,52% 10.721.900
02/01/2024 109,16 113,32 109,16 113,24 +3,87% 3,81% 11.920.100
29/12/2023 108,99 109,24 108,79 109,02 +0,23% 0,41% 5.889.200
28/12/2023 108,30 109,06 108,13 108,77 +0,73% 0,86% 5.530.400
27/12/2023 107,31 108,07 107,01 107,98 +0,33% 0,99% 5.387.000
26/12/2023 107,50 108,09 107,22 107,63 -0,06% 0,81% 4.727.700
22/12/2023 107,15 108,06 106,84 107,70 +1,23% 1,14% 6.028.700
21/12/2023 105,79 106,61 105,34 106,39 +0,98% 1,20% 5.919.400
20/12/2023 107,14 107,14 105,24 105,36 -1,06% 1,77% 8.441.600